U.S. stock futures traded higher this morning after recording gains in the previous session. Here are some big stocks recording gains in today’s pre-market trading session.
NGM Biopharmaceuticals Inc (NASDAQ:NGM) announced updated preliminary findings from its Phase 1b dose escalation trial of NGM120 in metastatic pancreatic cancer.…
NGM120 is a novel antagonist antibody that binds GFRAL and inhibits GDF15 signaling for the potential treatment of cancer
NGM120 has been well tolerated to date in patients in the Phase 1b combination cohort (NGM120 +
Benzinga Pro data, NGM Biopharmaceuticals (NASDAQ:NGM) reported Q2 sales of $8.29 million. Earnings fell to a loss of $46.52 million, resulting in a 43.36% decrease from last quarter.
On Friday, shares of NGM Biopharmaceuticals, Inc. (NASDAQ: NGM) experienced volatile short activity. After the activity, the stock price went up +3.21% to $15.74.
The overall sentiment for NGM has been Bearish.
Gainers
Agile Therapeutics, Inc. (NASDAQ: AGRX) shares climbed 89.8% to close at $2.41 on Tuesday. Agile Therapeutics shares climbed over 10% on Monday amid the Supreme Court overturning Roe V Wade.
Gainers
Agile Therapeutics, Inc. (NASDAQ: AGRX) jumped 88.9% to $2.3986. Agile Therapeutics shares climbed over 10% on Monday amid the Supreme Court overturning Roe V Wade.